Search Results - "Meng, Chao"

Refine Results
  1. 1

    Microvascular invasion predicts a poor prognosis of solitary hepatocellular carcinoma up to 2 cm based on propensity score matching analysis by Wang, Han, Wu, MengChao, Cong, Wen‐Ming

    Published in Hepatology research (01-03-2019)
    “…Aim Microvascular invasion (MVI) is not discussed for solitary hepatocellular carcinoma (HCC) up to 2 cm in the 8th Edition of the American Joint Committee on…”
    Get full text
    Journal Article
  2. 2

    Flexible Transparent Bifunctional Capacitive Sensors with Superior Areal Capacitance and Sensing Capability based on PEDOT:PSS/MXene/Ag Grid Hybrid Electrodes by Cheng, Tao, Yang, Xuan‐Li, Yang, Sheng, Li, Lang, Liu, Zhong‐Ting, Qu, Jie, Meng, Chao‐Fu, Li, Xiang‐Chun, Zhang, Yi‐Zhou, Lai, Wen‐Yong

    Published in Advanced functional materials (01-01-2023)
    “…Flexible transparent supercapacitors (FTSs) have aroused considerable attention. Nonetheless, balancing energy storage capability and transparency remains…”
    Get full text
    Journal Article
  3. 3

    Plasma circular RNA panel to diagnose hepatitis B virus‐related hepatocellular carcinoma: A large‐scale, multicenter study by Yu, Jian, Ding, Wen‐bing, Wang, Mengchao, Guo, Xing‐gang, Xu, Jian, Xu, Qing‐guo, Yang, Yuan, Sun, Shu‐han, Liu, Jing‐feng, Qin, Lun‐xiu, Liu, Hui, Yang, Fu, Zhou, Wei‐ping

    Published in International journal of cancer (15-03-2020)
    “…To explore whether plasma circular RNAs (circRNAs) can diagnose hepatitis B virus (HBV)‐related hepatocellular carcinoma (HCC), microarray and qPCR were used…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Early and Late Recurrence of Hepatitis B Virus‐Associated Hepatocellular Carcinoma by Wang, Ming‐Da, Li, Chao, Liang, Lei, Xing, Hao, Sun, Li‐Yang, Quan, Bing, Wu, Han, Xu, Xin‐Fei, Wu, MengChao, Pawlik, Timothy M., Lau, Wan Yee, Shen, Feng, Yang, Tian

    Published in The oncologist (Dayton, Ohio) (01-10-2020)
    “…Background Survival after liver resection of hepatocellular carcinoma (HCC) remains poor because of a high incidence of recurrence. We sought to investigate…”
    Get full text
    Journal Article
  7. 7

    Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT by Yin, Lei, Li, Hui, Li, Ai-Jun, Lau, Wan Yee, Pan, Ze-ya, Lai, Eric C.H, Wu, Meng-chao, Zhou, Wei-Ping

    Published in Journal of hepatology (01-07-2014)
    “…Background & Aims The aim of this randomized comparative trial (RCT) is to compare partial hepatectomy (PH) with transcatheter arterial chemoembolization…”
    Get full text
    Journal Article
  8. 8

    Tissue and serum metabolomic phenotyping for diagnosis and prognosis of hepatocellular carcinoma by Han, Jun, Han, Min‐lu, Xing, Hao, Li, Zhen‐li, Yuan, Dao‐yi, Wu, Han, Zhang, Han, Wang, Ming‐da, Li, Chao, Liang, Lei, Song, Yan‐yan, Xu, Ai‐jing, Wu, Mengchao, Shen, Feng, Xie, Ying, Yang, Tian

    Published in International journal of cancer (15-03-2020)
    “…More than two‐thirds of patients with hepatocellular carcinoma (HCC) cannot receive curative therapy and have poor survival due to late diagnosis and few…”
    Get full text
    Journal Article
  9. 9

    Selfing mutants link Ku proteins to mating type determination in Tetrahymena by Lin, I-Ting, Yao, Meng-Chao

    Published in PLoS biology (03-08-2020)
    “…Recognition of self and nonself is important for outcrossing organisms, and different mating types establish the barrier against self-mating. In the…”
    Get full text
    Journal Article
  10. 10

    Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China by Xu, Xin-Fei, Xing, Hao, Han, Jun, Li, Zhen-Li, Lau, Wan-Yee, Zhou, Ya-Hao, Gu, Wei-Min, Wang, Hong, Chen, Ting-Hao, Zeng, Yong-Yi, Li, Chao, Wu, Meng-Chao, Shen, Feng, Yang, Tian

    Published in JAMA surgery (01-03-2019)
    “…Late recurrence (more than 2 years) after liver resection for hepatocellular carcinoma (HCC) is generally considered as a multicentric tumor or a de novo…”
    Get more information
    Journal Article
  11. 11

    Causal Relationships Between Glycemic Traits and Myopia by Li, Fen-Fen, Zhu, Meng-Chao, Shao, Yi-Lei, Lu, Fan, Yi, Quan-Yong, Huang, Xiu-Feng

    “…Little is known about whether sugar intake is a risk factor for myopia, and the influence of glycemic control remains unclear, with inconsistent results…”
    Get full text
    Journal Article
  12. 12

    Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development by Wu, Kun, Ding, Jin, Chen, Cheng, Sun, Wen, Ning, Bei-Fang, Wen, Wen, Huang, Lei, Han, Tao, Yang, Wen, Wang, Chao, Li, Zhong, Wu, Meng-Chao, Feng, Gen-Sheng, Xie, Wei-Fen, Wang, Hong-Yang

    Published in Hepatology (Baltimore, Md.) (01-12-2012)
    “…Liver cirrhosis is a predominant risk factor for hepatocellular carcinoma (HCC). However, the mechanism underlying the progression from cirrhosis to HCC…”
    Get full text
    Journal Article
  13. 13

    MiR‐125a‐5p functions as a tumour suppressor in breast cancer by downregulating BAP1 by Yan, Liang, Yu, MengChao, Gao, Guang‐Lei, Liang, Hong‐Wei, Zhou, Xin‐Yan, Zhu, Zhou‐Ting, Zhang, Chen‐Yu, Wang, Ya‐Bing, Chen, Xi

    Published in Journal of cellular biochemistry (01-11-2018)
    “…MicroRNAs (miRNAs) play an important role in the regulation of human cancers, including breast cancer (BC). In the current study, we examined the expression…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Preparation of ultrafine Mo powder by the H2 reduction of MoO2: Parameter optimization, reaction kinetic, and its reduction mechanism by Li, Meng-Chao, Wang, Lu, Xue, Zheng-Liang

    “…The influences of different parameters, such as reaction temperature, yttrium (Y) content, and H2 concentration, on the particle size and morphological…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance by Meng, Chao-Yang, Sun, Shiyu, Liang, Yong, Xu, Hairong, Zhang, Chao, Zhang, Min, Wang, Fu-Sheng, Fu, Yang-Xin, Peng, Hua

    Published in Gut (01-08-2023)
    “…The purpose of this study is to develop an anti-PDL1-based interferon (IFN) fusion protein to overcome the chronic hepatitis B virus (HBV)-induced immune…”
    Get more information
    Journal Article
  19. 19

    Antiviral Therapy Reduces Hepatocellular Carcinoma Recurrence in Patients With Low HBV-DNA Levels: A Randomized Controlled Trial by Huang, Gang, Li, Peng-peng, Lau, Wan Yee, Pan, Ze-ya, Zhao, Ling-hao, Wang, Zhen-guang, Wang, Meng-chao, Zhou, Wei-ping

    Published in Annals of surgery (01-12-2018)
    “…BACKGROUND:Despite antiviral treatment has been shown to reduce hepatocellular carcinoma (HCC) recurrence after curative treatment for hepatitis B virus…”
    Get full text
    Journal Article
  20. 20

    Extracellular-vesicles delivered tumor-specific sequential nanocatalysts can be used for MRI-informed nanocatalytic Therapy of hepatocellular carcinoma by Wu, Han, Xing, Hao, Wu, Meng-Chao, Shen, Feng, Chen, Yu, Yang, Tian

    Published in Theranostics (01-01-2021)
    “…Conventional therapeutic strategies for advanced hepatocellular carcinoma (HCC) remains a great challenge, therefore the alternative therapeutic modality for…”
    Get full text
    Journal Article